HK1088066A1 - Peptides for discrimination of prions - Google Patents

Peptides for discrimination of prions

Info

Publication number
HK1088066A1
HK1088066A1 HK06108215.6A HK06108215A HK1088066A1 HK 1088066 A1 HK1088066 A1 HK 1088066A1 HK 06108215 A HK06108215 A HK 06108215A HK 1088066 A1 HK1088066 A1 HK 1088066A1
Authority
HK
Hong Kong
Prior art keywords
prions
discrimination
peptides
Prior art date
Application number
HK06108215.6A
Other languages
English (en)
Inventor
Jian Zheng
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Publication of HK1088066A1 publication Critical patent/HK1088066A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/968—Plasmin, i.e. fibrinolysin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK06108215.6A 2004-09-30 2006-07-24 Peptides for discrimination of prions HK1088066A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61453304P 2004-09-30 2004-09-30

Publications (1)

Publication Number Publication Date
HK1088066A1 true HK1088066A1 (en) 2006-10-27

Family

ID=35432058

Family Applications (2)

Application Number Title Priority Date Filing Date
HK06108215.6A HK1088066A1 (en) 2004-09-30 2006-07-24 Peptides for discrimination of prions
HK10101347.6A HK1137764A1 (en) 2004-09-30 2010-02-05 Peptides for discrimination of prions

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK10101347.6A HK1137764A1 (en) 2004-09-30 2010-02-05 Peptides for discrimination of prions

Country Status (14)

Country Link
EP (2) EP1643252B1 (ja)
JP (1) JP4837353B2 (ja)
KR (1) KR101355369B1 (ja)
CN (1) CN1804628B (ja)
AR (1) AR050965A1 (ja)
AT (2) ATE432473T1 (ja)
AU (1) AU2005209592B2 (ja)
BR (1) BRPI0504220A (ja)
CA (1) CA2518372C (ja)
DE (1) DE602005014597D1 (ja)
ES (2) ES2324919T3 (ja)
HK (2) HK1088066A1 (ja)
NZ (1) NZ542583A (ja)
PT (2) PT2085404E (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006076497A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Osplation of pathogenic prions
US7834144B2 (en) 2005-09-09 2010-11-16 Novartis Ag Prion-specific peptoid reagents

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806627A (en) 1987-05-29 1989-02-21 Research Foundation Of Mental Hygiene Inc. Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins
US5109464A (en) * 1991-05-24 1992-04-28 Amoco Corporation Rib waveguide optimized for low loss coupling to optical fibers and method of determining same
US20010001061A1 (en) 1997-02-21 2001-05-10 Prusiner Stanley B. Assay for disease related conformation of a protein
US6617119B2 (en) 1997-02-21 2003-09-09 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
EP0861900A1 (en) 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
US6165784A (en) 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
JP2003521477A (ja) 1999-06-23 2003-07-15 カプリオン ファーマシューティカルズ インコーポレーティッド プリオン蛋白質ペプチドおよびその使用
US6261790B1 (en) 1999-07-15 2001-07-17 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies
CA2385743A1 (en) 1999-09-28 2001-04-05 Universitat Zurich Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis
GB0014870D0 (en) * 2000-06-16 2000-08-09 King S College London Peptides
CA2413742A1 (en) 2000-06-26 2002-01-03 Universitat Zurich Prion-binding activity in serum and proteins
IL141950A0 (en) 2000-10-22 2002-03-10 Hadasit Med Res Service Diagnosis of prion diseases
AU2002241909A1 (en) 2001-01-19 2002-07-30 Baxter Healthcare S.A. Method of detecting prp protein and kits therefor
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
AU2003266801B2 (en) * 2002-12-19 2010-02-25 Ortho-Clinical Diagnostics, Inc Detection and diagnosis of transmissable spongiform encephalopathies

Also Published As

Publication number Publication date
AR050965A1 (es) 2006-12-06
AU2005209592B2 (en) 2012-07-12
EP2085404A1 (en) 2009-08-05
KR20060051862A (ko) 2006-05-19
ATE550666T1 (de) 2012-04-15
CA2518372A1 (en) 2006-03-30
JP4837353B2 (ja) 2011-12-14
EP1643252B1 (en) 2009-05-27
ES2382935T3 (es) 2012-06-14
ES2324919T3 (es) 2009-08-19
HK1137764A1 (en) 2010-08-06
AU2005209592A1 (en) 2006-04-13
EP2085404B1 (en) 2012-03-21
BRPI0504220A (pt) 2006-05-16
ATE432473T1 (de) 2009-06-15
EP1643252A2 (en) 2006-04-05
PT1643252E (pt) 2009-06-30
KR101355369B1 (ko) 2014-02-03
CA2518372C (en) 2013-07-09
NZ542583A (en) 2007-02-23
DE602005014597D1 (de) 2009-07-09
CN1804628B (zh) 2012-03-14
CN1804628A (zh) 2006-07-19
JP2006105988A (ja) 2006-04-20
EP1643252A3 (en) 2006-05-31
PT2085404E (pt) 2012-05-28

Similar Documents

Publication Publication Date Title
IL246171A0 (en) Peptide-based compounds
TWI372152B (en) Novel peptide compounds
EP1882292A4 (en) CONTACTLESS LOADING SYSTEM
HK1119441A1 (en) Toner
EP1944655A4 (en) TONER
PL1739093T3 (pl) Oddzielanie białek osocza
EP1962142A4 (en) TONER
IL182024A0 (en) Peptide cyclisation
EP1765392A4 (en) POLYPETPIDES INDUCING APOPTOSIS
GB0526120D0 (en) Therapeutic peptides
HK1137764A1 (en) Peptides for discrimination of prions
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
GB0404163D0 (en) Studs
EP1939286A4 (en) NEW PEPTIDE
GB2411526B (en) Water-safe cover for ceiling-rose
EP2097439A4 (en) NEW PEPTIDE
IL197675A0 (en) Peptides
ZA200709009B (en) Peptides having an ace inhibiting effect
ZA200702296B (en) Peptide cyclisation
ZA200708109B (en) Method of peptide synthesis
GB0520510D0 (en) Improved determinacy for spacewire
GB0423128D0 (en) Peptides
GB0425033D0 (en) Peptides
GB0523953D0 (en) Peptides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150929